Vestal Point Capital’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,160,000
Closed -$7.19M 77
2024
Q2
$7.19M Buy
1,160,000
+465,000
+67% +$2.88M 0.54% 40
2024
Q1
$6.56M Sell
695,000
-330,000
-32% -$3.12M 0.54% 37
2023
Q4
$6.92M Buy
+1,025,000
New +$6.92M 0.73% 30